Shkreli banned from the pharma industry; how much could seniors pay for Aduhelm?

"Pharma bro" Martin Shkreli was ordered Friday to pay $64.6 million in profits and was banned for life from the pharmaceutical industry. ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ 

STAT+: Martin Shkreli is ordered to pay $64 million and is banned from the pharma industry for life By Ed Silverman Mark Wilson/Getty Images “Shkreli was the prime mover in this anticompetitive scheme. It was his brainchild and he drove it each step of the way," the judge wrote. Read More No one has any idea how much money seniors could pay for new Alzheimer's drug By Rachel Cohrs Jessica Rinaldi/The Boston Globe Medicare has unveiled a plan to cover a controversial, expensive new Alzheimer's drug, but has not said how much patients might pay Read More Scientists are making CAR-T cells more clever. Here's what the next generation could look like By Angus Chen Molly Ferguson for STAT Scientists are working on the next generation of CAR-T therapies — from armored CARs to controllable CARs — to combat cancer. Read More Sponsor content by STAT Events The Breakthrough Science Summit: Early bird access! We’re gathering pharma executives, cutting-edge researchers, and key investors to break down the technologies and procedures pushing forward health and medicine. Together, we’ll explore the breakthroughs that have the potential to redefine care in the years to come. Join us there on Mar. 31! Get your ticket today and enjoy early bird pricing, available only through Jan. 14. Opinion: Eliminating the FDA's blood donation ban on men who have sex with men would help ease the U.S. shortage By Jason Silverstein Justin Sullivan/Getty Images Repealing an outdated, homophobic ban on blood donation by men who have sex with men could help ease the U.S. blood shortage crisis. Read More Opinion: STAT+: Patient engagement: The true benchmark in clinical trials By Catherine Gregor Adobe Patient engagement early in the clinical trial process leads to faster enrollment, higher retention, and better compliance. Read More Opinion: Public health is missing crucial data on LGBTQIA+ people. It's not hard to collect By Sean Cahill Adobe Data on sexual orientation and gender identity are relatively easy to collect. Why are so few public health entities doing it? Read More Friday, January 14, 2022       1 Exchange Pl, Suite 201, Boston, MA 02109 ©2022, All Rights Reserved. I no longer wish to receive STAT emails Update Email Preferences | Contact Us | View In Browser